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Abstract
Background: The validity of research synthesis is threatened if published studies comprise a
biased selection of all studies that have been conducted. We conducted a meta-analysis to ascertain
the strength and consistency of the association between study results and formal publication.
Methods:  The Cochrane Methodology Register Database, MEDLINE and other electronic
bibliographic databases were searched (to May 2009) to identify empirical studies that tracked a
cohort of studies and reported the odds of formal publication by study results. Reference lists of
retrieved articles were also examined for relevant studies. Odds ratios were used to measure the
association between formal publication and significant or positive results. Included studies were
separated into subgroups according to starting time of follow-up, and results from individual cohort
studies within the subgroups were quantitatively pooled.
Results: We identified 12 cohort studies that followed up research from inception, four that
included trials submitted to a regulatory authority, 28 that assessed the fate of studies presented
as conference abstracts, and four cohort studies that followed manuscripts submitted to journals.
The pooled odds ratio of publication of studies with positive results, compared to those without
positive results (publication bias) was 2.78 (95% CI: 2.10 to 3.69) in cohorts that followed from
inception, 5.00 (95% CI: 2.01 to 12.45) in trials submitted to regulatory authority, 1.70 (95% CI:
1.44 to 2.02) in abstract cohorts, and 1.06 (95% CI: 0.80 to 1.39) in cohorts of manuscripts.
Conclusion: Dissemination of research findings is likely to be a biased process. Publication bias
appears to occur early, mainly before the presentation of findings at conferences or submission of
manuscripts to journals.
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Background
Synthesis of published research is increasingly important
in providing relevant and valid research evidence to
inform clinical and health policy decision making. How-
ever, the validity of research synthesis based on published
literature is threatened if published studies comprise a
biased selection of the whole set of all conducted studies
[1].
The observation that many studies are never published
was termed "the file-drawer problem" by Rosenthal in
1979 [2]. The importance of this problem depends on
whether or not the published studies are representative of
all studies that have been conducted. If the published
studies are a random sample of all studies that have been
conducted, there will be no bias and the average estimate
based on the published studies will be similar to that
based on all studies. If the published studies comprise a
biased sample of all studies that have been conducted, the
results of a literature review will be misleading [3]. For
example, the efficacy of a treatment will be exaggerated if
studies with positive results are more likely to be pub-
lished than those with negative results.
Publication bias is defined as "the tendency on the parts
of investigators, reviewers, and editors to submit or accept
manuscripts for publication based on the direction or
strength of the study findings" [4]. The existence of publi-
cation bias was first suspected by Sterling in 1959, after
observing that 97% of studies published in four major
psychology journals provided statistically significant
results [5]. In 1995, the same author concluded that the
practices leading to publication bias had not changed over
a period of 30 years [6].
Evidence of publication bias can be classified as direct or
indirect [7]. Direct evidence includes the acknowledge-
ment of bias by those involved in the publication process
(investigators, referees or editors), comparison of the
results of published and unpublished studies, and the fol-
low-up of cohorts of registered studies [8]. Indirect evi-
dence includes the observation of disproportionately high
percentage of positive findings in the published literature,
and a larger effect size in small studies as compared with
large studies. This evidence is indirect because factors
other than publication bias may also lead to the observed
disparities.
In a Health Technology Assessment (HTA) report pub-
lished in 2000, we presented a comprehensive review of
studies that provided empirical evidence of publication
and related biases [8]. The review found that studies with
significant or favourable results were more likely to be
published, or were likely to be published earlier, than
those with non-significant or unimportant results. There
was limited and indirect evidence indicating the possibil-
ity of full publication bias, outcome reporting bias, dupli-
cate publication bias, and language bias. Considering that
the spectrum of the accessibility of research results (dis-
semination profile) ranges from completely inaccessible
to easily accessible, it was suggested that a single term 'dis-
semination bias' could be used to denote all types of pub-
lication and related biases [8].
Since then, many new empirical studies on publication
and related biases have been published. For example,
Egger et al provided further empirical evidence on publi-
cation bias, language bias, grey literature bias, and
MEDLINE index bias [9], and Moher et al evaluated lan-
guage bias in meta-analyses of randomised controlled tri-
als [10]. Recently, more convincing evidence on outcome
reporting bias has been published [11-13]. In addition, a
large number of studies of publication bias in conference
abstracts have been published [14]. As this new empirical
evidence may strengthen or contradict the empirical evi-
dence included in the previous review, we have updated
our review of dissemination bias, by synthesizing findings
from newly and previously identified studies [15]. This
paper focuses on findings from a review of cohort studies
that provided direct evidence on dissemination bias by
investigating the association between publication and
study results.
Methods
Criteria for inclusion
This review included any studies that tracked a cohort of
studies and reported the rate of publication by study
results. The relevant empirical studies may have tracked a
cohort of protocols approved by research ethics commit-
tees, registered by research funding bodies, submitted to
regulatory authorities, presented at conferences, or sub-
mitted to journals. Primary studies included in such
cohorts could be clinical trials, observational or basic
research. We separated the cohorts into four subgroups
according to stages in a simplified pathway of research
publication from inception to the journal publication
(Figure 1). A study that followed up a cohort of research
from the beginning (even if retrospectively) was termed
an inception cohort study. A regulatory cohort study refers
to a study that examined formal publication of clinical tri-
als submitted to regulatory authorities (such as the US
Food and Drug Administration or similar). An abstract
cohort study investigated the subsequent full publication
of abstracts presented at conferences. A manuscript cohort
study followed the publication fate of manuscripts sub-
mitted to journals. Studies that did not provide sufficient
data to compare the rates of publication between studies
with different results were excluded.BMC Medical Research Methodology 2009, 9:79 http://www.biomedcentral.com/1471-2288/9/79
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Literature Search strategy
The identification of cohort studies for this review was
conducted as part of a comprehensive search for empirical
and methodological studies on research dissemination
bias. We searched MEDLINE, the Cochrane Methodology
Register Database (CMRD), EMBASE, AMED and
CINAHL to August 2008 (see Additional file 1). PubMed,
PsycINFO and OpenSIGLE were searched in May 2009 to
locate more recently published studies. References (titles
with or without abstracts) identified by the MEDLINE and
CMRD searches were examined independently by two
reviewers, while those from other databases were assessed
by one reviewer. The reference lists of retrieved studies
and reviews were examined to identify additional studies.
Data Extraction and Synthesis
Data extraction included type of cohort, clinical speciality,
design of studies, duration of follow-up, definition of
study results, and the rate of publication by study results.
One reviewer extracted data directly into tables, which
were checked by a second reviewer.
The outcome, study publication, was usually defined as
full publication in a journal, but study results were often
categorised differently between included cohorts. We used
the classifications 'statistically significant (p ≤ 0.05)' ver-
sus 'non-significant (p > 0.05)' or 'positive' versus 'non-
positive'. Positive results included results that were con-
sidered to be 'significant', 'positive', 'favourable', 'impor-
tant', 'striking', 'showed effect', or 'confirmatory', while
non-positive results were labelled as being 'negative',
'non-significant', 'less or not important', 'invalidating',
'inconclusive', 'questionable', 'null', or 'neutral'.
The validity of the included cohort studies was not for-
mally assessed in this review, due to a lack of reliable tools
for assessment of methodological studies. However, we
tried to identify and summarise the main methodological
limitations in the included studies.
Data from the included studies were first summarised in
narrative form. The odds ratio was used as the outcome
statistic to measure the association between study results
and subsequent publication. In existing reviews of cohort
studies of publication bias, results from different studies
have been quantitatively combined [14,16,17], although
significant heterogeneity across individual studies has
lead to some controversy [18]. We felt it helpful to provide
pooled estimates after separating the included cohort
studies into appropriate subgroups, in order to improve
statistical power and generalisability. Results from indi-
vidual studies were quantitatively pooled using random-
effects meta-analysis. Heterogeneity within each subgroup
was measured using the I2 statistic, considering heteroge-
neity to be moderate or high when I2 is greater than 50%
[19]. Rucker et al pointed out that, given the same
between-study variance, the value of I2 will increase rap-
idly as the sample size of individual studies increases in
meta-analysis [20]. Therefore, clinical and methodologi-
cal relevance were the most important issue to consider
when deciding whether the results from individual studies
could be quantitatively combined in meta-analysis.
Funnel plots were used to assess the association between
the point estimates of log odds ratio (a measure of extent
of publication bias) and the precision of estimated log
odds ratio (inverse of standard errors). The visual assess-
ment of these plots was supported by a formal statistical
test using the regression method suggested by Peters et al
[21].
Results
Forty-eight cohort studies provided sufficient data to
assess rate of publication by study results. These consisted
of 12 inception cohort studies [22-33], four regulatory
cohort studies [34-37], 28 abstract cohort studies [38-65],
and four manuscript cohort studies [66-69]. Eight incep-
tion cohort studies were excluded because they did not
provide data on the results of unpublished studies or did
not examine the association between publication and
study results [12,13,70-75].
Pathway from research protocol to journal publication and  categories of research cohorts Figure 1
Pathway from research protocol to journal publica-
tion and categories of research cohorts.
Research protocol 
Data collection & analysis
Study results
Writing up 
Submitted to a journal
Conference
presentation
Formal publication
Inception cohort
Abstract cohort
Regulatory
authorities
Regulatory cohort
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Main characteristics of included cohort studies
The main characteristics of the included cohort studies are
summarised by subgroup in four additional files (Addi-
tional file 2, 3, 4 and 5). One inception cohort study [32]
and four abstract cohort studies [44,49,63,65] were avail-
able only in abstract form. Of the 12 cohort studies in the
inception subgroup, that assessed the fate of research
from its inception, eight did not restrict the field of
research, and four were limited to AIDS/HIV [29], health
effects of passive smoking [30], complementary medicine
[33], or eye diseases [32]. Of the four cohort studies in the
regulatory subgroup, two did not specify clinical fields
[34,36] and two included studies of anti-depressants
[35,37]. All of the cohort studies of conference abstracts
were restricted to a specific clinical field, such as emer-
gency medicine, anaesthesiology, perinatal studies, cystic
fibrosis, or oncology. Of the four cohorts of journal man-
uscripts, two examined manuscripts submitted to general
medical journals (JAMA, BMJ, Lancet, and Annals of Inter-
nal Medicine) [66,69] while two included manuscripts
submitted to the American version of the Journal of Bone
and Joint Surgery [67,68].
Four of the 12 cohort studies in the inception group, all
four studies in the regulatory group, and nine of the 28
cohort studies in the abstract group included only clinical
trials. The remaining cohort studies included research of
different designs, although separate data for clinical trials
was available in some of these studies. Follow-up time
ranged from 1 to 12 years in the inception cohort studies,
and from 2 to 5 years in the regulatory or abstract cohort
studies.
Authors of inception cohort studies used postal question-
naires or telephone interviews of investigators or both to
obtain information on results of unpublished studies. The
response rate to the survey of investigators ranged from
69% to 92% (see Additional file 2). Information on study
results was already available in five regulatory cohort stud-
ies and in all abstract cohort studies. Bibliographic data-
bases were usually searched to decide publication status.
Study results were categorised as statistically significant (p
< 0.05) or non-significant in 19 studies, and a wide range
of different methods were used to categorise study results
as, for example, positive versus negative, confirmatory ver-
sus inconclusive, striking versus unimportant.
Pooled estimates of publication bias
Table 1 summarises the main results of the meta-analyses.
The formal publication of statistically significant results
(p < 0.05) could be compared with that of non-significant
results in four inception cohort studies, one regulatory
cohort study, 12 abstract cohort studies and two manu-
script cohort studies (Figure 2). The rate of publication of
studies in the four inception cohorts ranged from 60% to
93% for significant results and from 20% to 86% for non-
significant results. The rate of full publication of meeting
abstracts ranged from 37% to 81% for statistically signifi-
cant results, and from 22% to 70% for non-significant
results. Heterogeneity across the four cohort studies from
the inception subgroup was statistically significant (I2 =
61%, p = 0.05). There was no statistically significant het-
erogeneity across studies within the cohort studies of
abstracts and cohort studies of manuscripts. The pooled
odds ratio for publication bias by statistical significance of
results was 2.40 (95% CI: 1.18 to 4.88) for the four incep-
tion cohort studies, 1.62 (95% CI: 1.34 to 1.96) for the 12
abstract cohort studies, and 1.15 (95% CI: 0.64 to 2.10)
for the two manuscript cohort studies (Figure 2). Only
one regulatory cohort study was included in Figure 2,
reported an odds ratio of 11.06 (95% CI: 0.56 to 21.9.7)
for publication of statistically significant vs. non-signifi-
cant results.
To include data from other cohort studies, a positive result
was loosely defined as important, confirmatory or signifi-
cant, while a 'non-positive' result included negative, non-
important, inconclusive or non-significant results. This
more inclusive definition of positive results allowed the
inclusion of all 12 inception cohort studies, four regula-
tory cohort studies, 27 abstract cohort studies, and four
manuscript cohort studies (Figure 3). There was statisti-
cally significant heterogeneity across cohort studies
within regulatory (p = 0.04) and abstract subgroups (p <
0.001). Pooled estimates of odds ratios consistently indi-
cated that studies with positive results were more likely to
be published than studies with non-positive results, but
this was not true after submission for publication (Figure
3).
Types of studies included in the cohort studies varied from
basic experimental, observational and qualitative research
to clinical trials. When the analyses were restricted to clin-
ical trials, the results were similar to that based on all stud-
ies, and there was no significant heterogeneity in the
extent of publication bias among the included inception
cohorts and abstract cohorts of clinical trials (Figure 4 and
Figure 5).
Funnel plots constructed separately for the four subgroups
of cohort studies were not statistically significantly asym-
metric (Figure 6).
Factors associated with publication bias
Some cohort studies have examined the impacts of other
factors on biased publication of research. The factors
investigated include study design, type of study, sample
size, funding source, and investigators' characteristics.
However, only a few of the included cohort studiesBMC Medical Research Methodology 2009, 9:79 http://www.biomedcentral.com/1471-2288/9/79
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reported findings regarding factors associated with publi-
cation bias and findings from different studies were often
inconsistent.
Easterbrook et al conducted subgroup analyses to exam-
ine susceptibility to publication bias amongst various sub-
groups of studies. They found that observational,
laboratory-based experimental studies and non-ran-
domised trials had a greater risk of publication bias than
randomised clinical trials. Factors associated with less bias
included a concurrent comparison group, a high investi-
gator rating of study importance and a sample size greater
than 20 [28].
Dickersin and colleagues investigated the association
between the risk of publication bias and type of study
(observational, clinical trial), multi or single centre, sam-
ple size, funding source and principle investigators' char-
acteristics (such as sex, degree, rank). They found no
statistically significant association between any factors
examined and publication bias [26]. In a different incep-
tion cohort study, Dickersin and Min reported that the
odds ratio for publication bias was significantly different
between multi-centre versus single centre studies, and
between studies with a female principle investigator and
studies with a male principle investigator [27]. They did
not find an association between publication bias and the
use of randomisation or blinding, having a comparison
group or a larger sample size [27].
Stern and Simes found that the risk of publication bias
tended to be greater for clinical trials (odds ratio 3.13,
95% CI: 1.76 to 5.58) than other studies (for all quantita-
tive studies odds ratio 2.32, 95% CI: 1.47 to 3.66). When
analyses were restricted to studies with a sample size
≥100, publication bias was still evident (hazard ratio 2.00,
95% CI: 1.09 to 3.66) [31].
Discussion
This updated analysis yielded results similar to previous
reviews: studies with statistically significant or positive
results are more likely to be formally published than those
with non-significant or non-positive results [14,16-18]. In
1997, Dickersin combined the results from four inception
cohort studies [26-28,31] and found that the pooled
adjusted odds ratio for publication bias (publication of
studies with significant or important results versus those
with unimportant results) was 2.54 (95% CI: 1.44 to
4.47) [16]. A recent systematic review of inception cohort
studies of clinical trials found the existence of publication
bias and outcome reporting bias, although pooled meta-
analysis was not conducted due to perceived differences
between studies [18]. A Cochrane methodology review of
publication bias by Hopewell et al[17] included five
inception cohort studies of trials registered before the
main results being known [22,26,27,29,31], in which the
pooled odds ratio for publication bias was 3.90 (95% CI:
2.68 to 5.68). In a Cochrane methodology review by
Scherer et al, the association between the subsequent full
publication and study results was examined in 16 of 79
abstract cohort studies [14], finding that the subsequent
full publication of conference abstracts was associated
with positive results (pooled OR = 1.28, 95% CI: 1.15 to
1.42).
Our review is the first to enable an explicit comparison of
results from cohort studies of publication bias with funda-
mentally different sampling frames. Biased selection for
publication may affect research dissemination over the
whole process from before study completion, to presenta-
tion of findings at conferences, manuscript submission to
journals, and formal publication in journals (Figure 1). It
seems that publication bias occurs mainly before the pres-
entation of findings at conferences and before the submis-
sion of manuscript to journals (Figure 2 and Figure 3).
Table 1: Results of meta-analyses of cohort studies of publication bias
Cohort category No. of cohort studies Pooled odds ratio
(95% CI)
Heterogeneity test:
I2 (p value)
Statistically significant versus non-significant results
Inception cohorts 4 2.40 (1.18 to 4.88) 61% (0.05)
Regulatory cohorts 1 11.06 (0.56 to 219.68)
Abstract cohorts 12 1.62 (1.34 to 1.96) 40% (0.08)
Manuscript cohorts 2 1.15 (0.64 to 2.10) 48% (0.17)
Positive versus non-positive results
Inception cohorts 12 2.78 (2.10 to 3.69) 37% (0.09)
Regulatory cohorts 4 5.00 (2.01 to 12.45) 64% (0.04)
Abstract cohorts 27 1.70 (1.44 to 2.02) 61% (<0.001)
Manuscript cohorts 4 1.06 (0.80 to 1.39) 22% (0.28)BMC Medical Research Methodology 2009, 9:79 http://www.biomedcentral.com/1471-2288/9/79
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Rate of publication of statistically significant versus non-significant results - all studies Figure 2
Rate of publication of statistically significant versus non-significant results - all studies.
Study or Subgroup
1.1.1 Inception cohorts
Easterbrook 1991
Misakian 1998
Stern 1997a
Wormald 1997
Subtotal (95% CI)
Total events
Heterogeneity: Tau² = 0.27; Chi² = 7.65, df = 3 (P = 0.05); I² = 61%
Test for overall effect: Z = 2.42 (P = 0.02)
1.1.2 Regulatory cohorts
Melander 2003
Subtotal (95% CI)
Total events
Heterogeneity: Not applicable
Test for overall effect: Z = 1.58 (P = 0.12)
1.1.4 Abstract cohorts
Akbari 2008
Castillo 2002
Eloubeidi 2001
Evers 2000
Glick 2006
Harris 2006
Harris 2007
Krzyzanowska 2003
Scherer 1994
Smith 2007
Timmer 2002
Zamakhashary 2006
Subtotal (95% CI)
Total events
Heterogeneity: Tau² = 0.04; Chi² = 18.24, df = 11 (P = 0.08); I² = 40%
Test for overall effect: Z = 4.97 (P < 0.00001)
1.1.5 Manuscripts to journals
Lee 2006
Olson 2002
Subtotal (95% CI)
Total events
Heterogeneity: Tau² = 0.10; Chi² = 1.91, df = 1 (P = 0.17); I² = 48%
Test for overall effect: Z = 0.47 (P = 0.64)
Events
93
29
99
14
235
21
21
23
160
36
41
208
12
69
181
33
521
177
105
1566
35
78
113
Total
154
40
146
15
355
21
21
45
361
98
69
397
24
101
223
46
1120
354
151
2989
718
383
1101
Events
45
18
27
15
105
17
17
22
23
77
38
95
49
106
195
28
86
69
13
801
7
55
62
Total
131
21
72
21
245
21
21
44
56
353
82
234
176
217
287
47
202
147
32
1877
109
362
471
Weight
39.2%
16.6%
36.0%
8.3%
100.0%
100.0%
100.0%
4.3%
7.5%
9.3%
6.3%
13.7%
4.0%
9.0%
10.9%
4.0%
14.5%
11.8%
4.7%
100.0%
32.7%
67.3%
100.0%
M-H, Random, 95% CI
2.91 [1.80, 4.73]
0.44 [0.11, 1.79]
3.51 [1.95, 6.33]
5.60 [0.60, 52.54]
2.40 [1.18, 4.88]
11.06 [0.56, 219.68]
11.06 [0.56, 219.68]
1.05 [0.46, 2.40]
1.14 [0.64, 2.02]
2.08 [1.29, 3.37]
1.70 [0.89, 3.24]
1.61 [1.16, 2.23]
2.59 [1.09, 6.16]
2.26 [1.37, 3.71]
2.03 [1.34, 3.09]
1.72 [0.72, 4.10]
1.17 [0.87, 1.59]
1.13 [0.77, 1.66]
3.34 [1.52, 7.32]
1.62 [1.34, 1.96]
0.75 [0.32, 1.73]
1.43 [0.98, 2.09]
1.15 [0.64, 2.10]
Significant Non-significant Odds Ratio Odds Ratio
M-H, Random, 95% CI
0.01 0.1 1 10 100
Favours non-significant Favours significantBMC Medical Research Methodology 2009, 9:79 http://www.biomedcentral.com/1471-2288/9/79
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Rate of publication of positive versus non-positive results - all studies Figure 3
Rate of publication of positive versus non-positive results - all studies.
Study or Subgroup
2.1.1 Inception cohorts
Bardy 1998
Cronin 2004
Decullier 2005
Decullier 2006
Dickersin 1992
Dickersin 1993
Easterbrook 1991
Ioannidis 1998
Misakian 1998
Stern 1997
Wormald 1997
Zimpel 2000
Subtotal (95% CI)
Total events
Heterogeneity: Tau² = 0.08; Chi² = 17.53, df = 11 (P = 0.09); I² = 37%
Test for overall effect: Z = 7.10 (P < 0.00001)
2.1.3 Regulatory cohorts
Lee 2008
Melander 2003
Rising 2008
Turner 2008
Subtotal (95% CI)
Total events
Heterogeneity: Tau² = 0.45; Chi² = 8.35, df = 3 (P = 0.04); I² = 64%
Test for overall effect: Z = 3.46 (P = 0.0005)
2.1.4 Abstract cohorts
Akbari 2008
Brazzelli 2009
Callaham 1998
Castillo 2002
Cheng 1998
De Bellefeuille 1992
Delamere 2005
Eloubeidi 2001
Evers 2000
Glick 2006
Ha 2008
Halpern 2001
Harris 2006
Harris 2007
Hashkes 2003
Kiroff 2001
Klassen 2002
Krzyzanowska 2003
Landry 1996
Peng 2006
Petticrew 1999
Sanossian 2006
Scherer 1994
Smith 2007
Timmer 2002
Vecchi 2006
Zamakhashary 2006
Subtotal (95% CI)
Total events
Heterogeneity: Tau² = 0.10; Chi² = 66.82, df = 26 (P < 0.0001); I² = 61%
Test for overall effect: Z = 6.19 (P < 0.00001)
2.1.5 Manuscripts to journals
Lee 2006
Lynch 2007
Okike 2008
Olson 2002
Subtotal (95% CI)
Total events
Heterogeneity: Tau² = 0.02; Chi² = 3.83, df = 3 (P = 0.28); I² = 22%
Test for overall effect: Z = 0.39 (P = 0.69)
Events
52
26
129
26
259
121
93
20
29
153
14
43
965
285
21
102
37
445
59
107
77
160
43
48
15
36
41
208
288
29
45
123
54
98
162
148
24
189
18
136
33
521
177
120
105
3064
35
45
132
78
290
Total
111
34
188
37
314
124
154
27
40
232
15
107
1383
432
21
124
38
615
137
141
153
361
113
65
22
98
69
397
982
83
132
203
112
139
235
183
58
337
36
220
46
1120
354
161
151
6108
718
148
620
383
1869
Events
16
23
17
6
131
63
45
16
18
36
15
15
401
52
17
25
14
108
3
13
36
23
14
67
1
77
38
399
13
9
17
53
38
76
93
229
20
13
21
83
28
86
213
239
13
1915
7
19
54
55
135
Total
77
36
60
10
200
74
131
39
21
89
21
53
811
144
21
39
36
240
8
19
74
56
42
132
8
353
82
750
115
47
68
115
145
159
187
327
110
26
41
133
47
202
482
420
32
4180
109
61
235
362
767
Weight
10.6%
5.7%
11.0%
3.3%
16.5%
3.9%
14.6%
5.5%
3.5%
14.1%
1.5%
9.7%
100.0%
43.8%
7.8%
34.9%
13.5%
100.0%
1.1%
1.9%
4.0%
3.9%
3.0%
3.5%
0.5%
4.5%
3.5%
6.2%
3.8%
2.5%
3.4%
4.6%
4.2%
4.5%
5.1%
4.8%
3.1%
2.7%
2.4%
4.8%
2.5%
5.8%
6.0%
5.0%
2.8%
100.0%
9.9%
15.7%
38.5%
35.8%
100.0%
M-H, Random, 95% CI
3.36 [1.73, 6.53]
1.84 [0.65, 5.22]
5.53 [2.91, 10.49]
1.58 [0.37, 6.71]
2.48 [1.64, 3.74]
7.04 [1.90, 26.16]
2.91 [1.80, 4.73]
4.11 [1.41, 11.99]
0.44 [0.11, 1.79]
2.85 [1.72, 4.71]
5.60 [0.60, 52.54]
1.70 [0.84, 3.47]
2.78 [2.10, 3.69]
3.43 [2.31, 5.09]
11.06 [0.56, 219.68]
2.60 [1.17, 5.78]
58.14 [7.15, 473.03]
5.00 [2.01, 12.45]
1.26 [0.29, 5.49]
1.45 [0.51, 4.12]
1.07 [0.61, 1.86]
1.14 [0.64, 2.02]
1.23 [0.58, 2.59]
2.74 [1.43, 5.25]
15.00 [1.54, 146.54]
2.08 [1.29, 3.37]
1.70 [0.89, 3.24]
0.97 [0.76, 1.24]
3.26 [1.80, 5.89]
2.27 [0.96, 5.33]
1.55 [0.80, 2.99]
1.80 [1.13, 2.86]
2.62 [1.55, 4.43]
2.61 [1.62, 4.22]
2.24 [1.51, 3.34]
1.81 [1.17, 2.80]
3.18 [1.56, 6.48]
1.28 [0.57, 2.84]
0.95 [0.39, 2.33]
0.98 [0.63, 1.52]
1.72 [0.72, 4.10]
1.17 [0.87, 1.59]
1.26 [0.96, 1.66]
2.22 [1.48, 3.32]
3.34 [1.52, 7.32]
1.70 [1.44, 2.02]
0.75 [0.32, 1.73]
0.97 [0.51, 1.84]
0.91 [0.63, 1.30]
1.43 [0.98, 2.09]
1.06 [0.80, 1.39]
Positive Non-positive Odds Ratio Odds Ratio
M-H, Random, 95% CI
0.1 0.2 0.5 1 2 5 10
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Rate of publication of statistically significant versus non-significant results - clinical trials only Figure 4
Rate of publication of statistically significant versus non-significant results - clinical trials only.
Study or Subgroup
3.1.1 Inception cohorts
Stern 1997a
Wormald 1997
Subtotal (95% CI)
Total events
Heterogeneity: Tau² = 0.00; Chi² = 0.00, df = 1 (P = 0.96); I² = 0%
Test for overall effect: Z = 4.55 (P < 0.00001)
3.1.3 Regulatory cohorts
Melander 2003
Subtotal (95% CI)
Total events
Heterogeneity: Not applicable
Test for overall effect: Z = 1.58 (P = 0.12)
3.1.4 Abstract cohorts
Akbari 2008
Evers 2000
Krzyzanowska 2003
Scherer 1994
Timmer 2002
Subtotal (95% CI)
Total events
Heterogeneity: Tau² = 0.00; Chi² = 2.01, df = 4 (P = 0.73); I² = 0%
Test for overall effect: Z = 4.10 (P < 0.0001)
3.1.5 Manuscripts to journals
Olson 2002
Subtotal (95% CI)
Total events
Heterogeneity: Not applicable
Test for overall effect: Z = 1.84 (P = 0.07)
Events
55
14
69
21
21
23
41
181
33
84
362
78
78
Total
76
15
91
21
21
45
69
223
46
140
523
383
383
Events
18
15
33
17
17
22
38
195
28
47
330
55
55
Total
54
21
75
21
21
44
82
287
47
99
559
362
362
Weight
89.7%
10.3%
100.0%
100.0%
100.0%
9.9%
16.3%
39.3%
9.1%
25.4%
100.0%
100.0%
100.0%
M-H, Random, 95% CI
5.24 [2.46, 11.17]
5.60 [0.60, 52.54]
5.27 [2.57, 10.80]
11.06 [0.56, 219.68]
11.06 [0.56, 219.68]
1.05 [0.46, 2.40]
1.70 [0.89, 3.24]
2.03 [1.34, 3.09]
1.72 [0.72, 4.10]
1.66 [0.99, 2.79]
1.73 [1.33, 2.25]
1.43 [0.98, 2.09]
1.43 [0.98, 2.09]
Significant Non-significant Odds Ratio Odds Ratio
M-H, Random, 95% CI
0.05 0.2 1 5 20
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Rate of publication of positive versus non-positive results - clinical trials only Figure 5
Rate of publication of positive versus non-positive results - clinical trials only.
Study or Subgroup
4.1.1 Inception cohorts
Bardy 1998
Dickersin 1992
Dickersin 1993
Ioannidis 1998
Stern 1997
Wormald 1997
Subtotal (95% CI)
Total events
Heterogeneity: Tau² = 0.00; Chi² = 1.81, df = 5 (P = 0.87); I² = 0%
Test for overall effect: Z = 6.89 (P < 0.00001)
4.1.3 Regulatory cohorts
Lee 2008
Melander 2003
Rising 2008
Turner 2008
Subtotal (95% CI)
Total events
Heterogeneity: Tau² = 0.45; Chi² = 8.35, df = 3 (P = 0.04); I² = 64%
Test for overall effect: Z = 3.46 (P = 0.0005)
4.1.4 Abstract cohorts
Akbari 2008
Cheng 1998
Delamere 2005
Evers 2000
Klassen 2002
Krzyzanowska 2003
Scherer 1994
Timmer 2002
Vecchi 2006
Subtotal (95% CI)
Total events
Heterogeneity: Tau² = 0.00; Chi² = 6.35, df = 8 (P = 0.61); I² = 0%
Test for overall effect: Z = 6.88 (P < 0.00001)
4.1.5 Manuscripts to journals
Olson 2002
Subtotal (95% CI)
Total events
Heterogeneity: Not applicable
Test for overall effect: Z = 1.84 (P = 0.07)
Events
52
84
121
20
69
14
360
285
21
102
37
445
59
43
15
41
162
148
33
84
120
705
78
78
Total
111
96
124
27
100
15
473
432
21
124
38
615
137
113
22
69
235
183
46
140
161
1106
383
383
Events
16
52
63
16
27
15
189
52
17
25
14
108
3
14
1
38
93
229
28
86
239
731
55
55
Total
77
72
74
39
67
21
350
144
21
39
36
240
8
42
8
82
187
327
47
186
420
1307
362
362
Weight
28.7%
20.1%
7.4%
11.0%
30.3%
2.5%
100.0%
43.8%
7.8%
34.9%
13.5%
100.0%
1.6%
6.2%
0.7%
8.3%
21.8%
18.1%
4.6%
17.5%
21.2%
100.0%
100.0%
100.0%
M-H, Random, 95% CI
3.36 [1.73, 6.53]
2.69 [1.22, 5.96]
7.04 [1.90, 26.16]
4.11 [1.41, 11.99]
3.30 [1.73, 6.29]
5.60 [0.60, 52.54]
3.50 [2.45, 4.99]
3.43 [2.31, 5.09]
11.06 [0.56, 219.68]
2.60 [1.17, 5.78]
58.14 [7.15, 473.03]
5.00 [2.01, 12.45]
1.26 [0.29, 5.49]
1.23 [0.58, 2.59]
15.00 [1.54, 146.54]
1.70 [0.89, 3.24]
2.24 [1.51, 3.34]
1.81 [1.17, 2.80]
1.72 [0.72, 4.10]
1.74 [1.12, 2.72]
2.22 [1.48, 3.32]
1.92 [1.60, 2.31]
1.43 [0.98, 2.09]
1.43 [0.98, 2.09]
Positive Non-positive Odds Ratio Odds Ratio
M-H, Random, 95% CI
0.1 0.2 0.5 1 2 5 10
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The subsequent publication of conference abstracts was
still biased but the extent of publication bias tended to be
smaller as compared to all studies conducted. After the
submission of a manuscript for publication, editorial
decisions were not clearly associated with study results.
However, publication bias may still be an issue for
rejected manuscripts, if the possibility of their re-submis-
sion to a different journal is associated with the study
results. One excluded cohort study (in which data on pub-
lication bias was not available) found that psychological
research with statistically significant results was more
likely to be submitted for publication than research with
non-significant results (74% versus 4%) [72].
Since the acceptance of manuscripts for publication by
journal editors was not determined by the direction or
strength of study results, the existence of publication bias
may be largely due to biased selection by investigators of
submitted studies. This is supported by data suggesting
that a large proportion of submitted papers show signifi-
cant or positive results (72%) in four cohort studies
(Table 2). Since authors inevitably consider the possibility
of their manuscripts being rejected before the submission,
submitted studies with negative results may be a biased
selection of all studies with negative results. In addition,
although no conflict of interest was declared in the four
cohort studies of submitted manuscripts, this kind of
study will always need support or collaboration from
journal editors. In prospective studies, editors' decision
on manuscript acceptance may be influenced by their
awareness of the ongoing study [69]. Therefore, biased
selection for publication by journals cannot be com-
pletely ruled out. In Olson et al's cohort study of manu-
scripts submitted to JAMA, there was a tendency that
studies with significant results had a higher rate of accept-
ance than studies with non-significant or unclear results
(20.4% vs 15.2%, p = 0.07) [69]. In the cohort study by
Okike et al, a subgroup analysis of 156 manuscripts with
a high level of evidence (level I or II) found that the
acceptance rate was significantly higher for studies with
positive or neutral results than studies with negative
results (37%, 36% and 5% respectively; p = 0.02) [68].
Funnel plots -- publication of positive and non-positive results Figure 6
Funnel plots -- publication of positive and non-positive results. (Funnel plot asymmetry test: p = 0.178 for inception 
cohort studies, p = 0.262 for regulatory cohort studies, p = 0.142 for abstract cohort studies, and p = 0.942 for manuscript 
cohort studies.)
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Important and convincing evidence on the existence of
publication bias comes from the inception cohort studies.
Study results were defined differently among the empiri-
cal studies assessing publication bias. The most objective
method would be to classify quantitative results as statis-
tically significant (p < 0.05) or not. However, this was not
always possible or appropriate. When other methods were
used to classify study results as important or not, bias may
be introduced due to inevitable subjectivity.
Large cohort studies on publication bias were often highly
diverse in terms of research questions, designs, and other
study characteristics. Many factors (e.g., sample size,
design, research question, and investigators' characteris-
tics) may confound the association as they are associated
with both study results and the possibility of publication.
However, due to insufficient data, it was impossible to
exclude the impact of confounding factors on the
observed association between study results and formal
publication. To improve our understanding of factors
associated with publication bias findings from qualitative
research on the process of research dissemination may be
helpful [76,77].
There was a statistically significant heterogeneity within
subgroups of inception, regulatory and abstract cohort
studies (Table 1), although restricting analyses to clinical
trials reduced the heterogeneity (Figure 4 and 5). The
observed heterogeneity may be a result of differences in
study designs, research questions, how the cohorts were
assembled, definitions of study results, and so on. For
example, the significant heterogeneity across inception
cohort studies was due to one study by Misakian and Bero
(Figure 2 and Figure 3) [30]. After excluding this cohort
study, there was no longer significant heterogeneity across
inception cohort studies (see Notes to Figure 2 and Figure
3). The cohort study by Misakian and Bero included
research on health effects of passive smoking, and the
impact of statistical significance of results on publication
may be different from studies of other research topics
[30].
The four cohorts of trials submitted to regulatory authori-
ties showed a greater extent of publication bias than other
subgroups of cohort studies (Figure 3) [34-37]. Only 855
primary studies were included in the regulatory cohort
studies, and two of the four regulatory cohort studies
focused on trials of antidepressants [35,37]. Therefore,
these regulatory cohort studies may be a biased selection
of all possible cases.
Studies of publication bias themselves may be as vulnera-
ble as other studies to the selective publication of signifi-
cant or striking findings [1,78-80]. In this review, the
funnel plot asymmetry was non-significant for each of the
four research cohorts (Figure 6). However, we identified a
large number of reports of full publication of meeting
abstracts, and the association between study results and
full publication had not been reported in most of these
reports. It is often unclear whether this association had
not been examined, or was not reported because the asso-
ciation proved to be non-significant. As an example,
Zaretsky and Imrie reported no significant difference (p =
0.53) in the rate of subsequent publication of 57 meeting
abstracts between statistically significant and non-signifi-
cant results; but this study could not be included in the
analysis due to insufficient data [65].
Implications
Despite many caveats regarding the available empirical
evidence on publication bias, there is little doubt that dis-
semination of research findings is likely to be a biased
process. All funded or approved studies should be pro-
spectively registered and these registers should be publicly
accessible. Regulatory authorities should also provide
publicly accessible databases of all studies received from
pharmaceutical industry. Investigators should be encour-
aged and supported to present their studies at confer-
ences. A thorough literature search should be conducted
in systematic reviews to identify all relevant studies,
including searches of registers of clinical trials and availa-
ble databases of unpublished studies.
Conclusion
There is consistent empirical evidence that the publication
of a study that exhibits statistically significant or 'impor-
tant' results is more likely to occur than the publication of
a study that does not show such results. Indirect evidence
indicates that publication bias occurs mainly before the
presentation of findings at conferences and the submis-
sion of manuscripts to journals.
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